Background:
Herpes Zoster is a reactivation of a latent infection withVaricella-Zoster Virus (VZV) in a sensory ganglia, often
triggered by age-related immunosenescence and immunocompromised state.
Maxillary branch of the trigeminal nerve is rarely affected in this
infection and approximately seen in 1.7% of the cases [1]. Among
risk factors of herpes zoster, vaccines are not common. Recently, cases
of VZV reactivation after COVID-19 vaccine have been reported in the
litterature [2,3].
Here, we report a case of an herpes zoster involving the maxillary nerve
in a 66 year-old immunocompetent female, that appeared 5 days after the
first dose of viral vector COVID-19 vaccination.